Find Stability with an Insurance Verified Injectable MAT Program

Find Stability with an Insurance Verified Injectable MAT Program

When you enroll in an insurance verified injectable MAT program, you gain consistent access to medically supervised, monthly injections that help you maintain stability in recovery. Unlike daily pills or take-home doses, these treatments deliver a steady dose of medication without the risk of missed doses or diversion. With our long acting injectable opioid dependency treatment options, you can focus on healing rather than on filling prescriptions or managing complex dosing schedules.

Injectable medication-assisted treatment (MAT) combines FDA-approved medications with counseling and support services to address both the physical dependence and psychological aspects of opioid or alcohol use disorders. Two leading options—Sublocade and Vivitrol—offer extended-release formulations designed for monthly administration, making it easier to stay on track and reduce cravings. Whether you’re stabilizing opioid use disorder or preventing relapse after detox, our insurance verified injectable MAT program provides the structure and support necessary for lasting recovery.

Long acting injectable treatment

What is injectable MAT

Injectable MAT delivers medication through a once-monthly injection rather than daily oral doses. This approach:

  • Ensures steady blood levels of buprenorphine or naltrexone
  • Reduces the burden of daily adherence
  • Lowers the risk of diversion or misuse

By removing daily pill management, you gain more freedom to focus on therapy, work, family, and personal growth.

Comparing Sublocade and Vivitrol

Each injectable option has unique features suited to different stages of recovery:

Feature Sublocade Vivitrol
Active medication Buprenorphine extended release Naltrexone extended release
Indication Opioid use disorder stabilization Opioid or alcohol relapse prevention
Administration site Subcutaneous abdominal injection Intramuscular gluteal injection
Dosing schedule Monthly Monthly
Mechanism Partial opioid agonist with blocker properties full opioid receptor blockade

Coverage considerations:

Benefits of injectable therapies

Enhanced adherence and stability

  • Monthly injections free you from daily pill routines
  • Consistent medication levels help minimize cravings
  • Reduced chance of missed doses supports continuous recovery

Reduced stigma and triggers

  • No visible pill bottles or pharmacy trips
  • Privacy around your treatment protocol
  • Less exposure to environmental cues that can prompt relapse

Improved relapse prevention

  • Extended-release formulas maintain blockade or partial activation for weeks
  • You can focus on therapy and skill-building without medication worries
  • Studies show injectable MAT lowers relapse rates compared to oral regimens

Insurance coverage overview

Coverage frameworks

Most private, employer-sponsored, marketplace and Medicaid plans must cover MAT under the 2008 Mental Health Parity and Opioid Dependency Equity Act, providing benefits comparable to medical or surgical care [1]. Additionally, Medicare covers services provided by Opioid Treatment Programs—including administration of injectable naltrexone—under certain benefit categories [2]. Despite these mandates, less than 40 percent of publicly funded treatment programs offer MAT medications, making insurance verification a critical first step [3].

Vivitrol coverage highlights

  • 99 percent of people with any insurance (including Medicaid) are covered for Vivitrol [4]
  • Nine out of ten eligible Vivitrol patients pay less than $5 out of pocket per injection
  • Medicaid patients typically pay $4 or less per dose
  • Eligible individuals with commercial or no insurance may pay $0 per prescription, with maximum savings up to $500 per injection (up to $6,000 per year)

Sublocade coverage guidance

  • Coverage for extended-release buprenorphine can require prior authorization
  • Medicaid policies vary by state; your care team will clarify any requirements
  • We handle insurance verification and appeals so you can start treatment promptly

Program options at Carolina Energetics

Monthly sublocade treatment program

Our monthly sublocade treatment program provides:

  • Individualized dosing plans based on clinical assessment
  • On-site injections by trained nurses
  • Integrated medication management and medical oversight

Vivitrol program outpatient clinic

Through our vivitrol program outpatient clinic, you’ll receive:

  • Monthly intramuscular injections delivered in a comfortable, confidential setting
  • Coordination with your prescriber for seamless care transitions
  • Access to peer support and educational resources

Integrating counseling and support

Tailored therapy integration

Injectable MAT is most effective when combined with counseling. Our teams specialize in sublocade and counseling integration, ensuring your therapy plan addresses underlying issues and strengthens coping skills.

Peer recovery coaching

Working with a certified peer recovery coach—someone who has navigated their own recovery—boosts motivation and accountability. Studies show peer support improves retention and treatment outcomes [5].

Telehealth follow-up

After each injection, you can check in via telehealth to discuss progress, side effects, or any concerns. Regular virtual visits keep your care team updated and responsive to your needs.

Starting your injectable treatment

Initial assessment and planning

Your journey begins with a comprehensive evaluation by a physician or nurse practitioner. You’ll discuss:

  • Your substance use history and treatment goals
  • Medical and mental health needs
  • Any required detoxification or transition protocols

Together, you’ll develop an individualized plan that may include Sublocade or Vivitrol.

Insurance verification and financial assistance

Our billing specialists confirm your coverage and explore cost-saving programs:

  • We enroll qualified Vivitrol patients in the manufacturer’s co-pay savings program
  • We pursue prior authorizations for Sublocade on your behalf
  • Sliding-scale fees or grant funding may be available if gaps arise

Scheduling your first injection

Once your plan is finalized, our staff will contact you to arrange your initial appointment. You’ll receive clear instructions on any pre-injection preparation and what to expect during your visit.

Sustaining long‐term recovery

Ongoing monitoring and maintenance

Consistent follow-up visits allow your provider to monitor progress, adjust dosing if needed, and address any emerging concerns. Laboratory testing may be used periodically to ensure medication levels remain therapeutic.

Relapse prevention services

We offer structured relapse prevention strategies, including:

Holistic support offerings

Recovery thrives when mind and body are nurtured. You can access:

  • Meditation and mindfulness sessions
  • Nutrition and exercise guidance
  • Family education and support groups

Begin your recovery journey

If you’re ready to maintain your recovery with a proven, insurance‐verified injectable MAT program, our team at Carolina Energetics is here for you. Take the first step by finding a sublocade treatment provider near me or contacting our outpatient clinic to learn more. We’re committed to helping you build a stable, fulfilling life in recovery.

References

  1. (American opioid dependency Centers)
  2. (CMS.gov)
  3. (NCBI)
  4. (VIVITROL)
  5. (Recovery In Motion)

Start Your Healing Journey with Carolina Energetics PC

Ready to begin your path to recovery? Contact us now to schedule a consultation and experience the difference of personalized, professional care in a welcoming environment.

Office Hours
Blood Testing Hours
Urine Testing Hours

Save Buprenorphine

Buprenorphine is under threat—and so are the patients who depend on it.

This life-saving medication is now listed as a “suspicious drug,” leading many pharmacies to stop dispensing it altogether. The DEA is pushing for everyone to switch to Buprenorphine/Naloxone (Suboxone), but not every patient can tolerate Naloxone. Many experience severe side effects or have legitimate sensitivity—even when allergy tests fail to detect it.

We’ve seen firsthand the damage this policy shift is causing.

We need your voice. Congressmen Paul Tonko and Senator Martin Heinrich are sponsoring a bill to protect access to Buprenorphine, and bipartisan support is growing. We urge you to contact your state Senators and President Trump online to support this bill. Your advocacy could help restore patient choice and save lives.

Don’t let politics get in the way of proper care. Help us protect access to Buprenorphine.